O'Day, S., Pavlick, A., Loquai, C., Lawson, D., Gutzmer, R., Richards, J., . . . Ho, P. (2011). A randomised, phase II study of intetumumab, an anti-α(v)-integrin mAb, alone and with dacarbazine in stage IV melanoma. Nature Publishing Group.
Chicago Style citaatO'Day, S., et al. A Randomised, Phase II Study of Intetumumab, an Anti-α(v)-integrin MAb, Alone and With Dacarbazine in Stage IV Melanoma. Nature Publishing Group, 2011.
MLA citatieO'Day, S., et al. A Randomised, Phase II Study of Intetumumab, an Anti-α(v)-integrin MAb, Alone and With Dacarbazine in Stage IV Melanoma. Nature Publishing Group, 2011.
Let op: Deze citaties zijn niet altijd 100% accuraat.